本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

157.83
-3.6900-2.28%
成交量:13.13萬
成交額:2,082.19萬
市值:95.29億
市盈率:-25.08
高:165.26
開:161.78
低:156.28
收:161.52
資料載入中...
2023/09/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/05

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals